Trastuzumab Active Not Recruiting Phase 3 Trials for HER2-positive Carcinoma of Breast Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02162667Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer